Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both?

Affiliations

• ¹ MACVIA-LR, Contre les Maladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, Languedoc-Roussillon, France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France INSERM, VIMA: Ageing and chronic diseases, Epidemiological and public health approaches, U1168, Paris, France UVSQ, UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Versailles, France [email protected].
• ² Service de physiologie respiratoire, Hôpital Cochin, Université Paris-Descartes, Assistance publique-Hôpitaux de Paris, Paris, France.
• ³ UMR_S 1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Universités, UPMC Univ Paris 06, INSERM, Paris, France.
• ⁴ Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
• ⁵ Gerontology Center, Site Sainte Périne, Université de Versailles St Quentin, Paris, France.
• ⁶ Dept of Internal Medicine (DIBIMIS), University of Palermo, Palermo, Italy.
• ⁷ Dept of Metabolic Medicine, University of Modena and Reggio Emilia, Sant'Agostino Estense Hospital, Modena, Italy.
• ⁸ Université Paris-Sud, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
• ⁹ Dept of Physiology, CHRU, University Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
• ¹⁰ Centre of Pneumology, Coimbra University Hospital, Coimbra, Portugal.
• ¹¹ Dept of Geriatrics, Getafe University Hospital, Madrid, Spain.
• ¹² Gérontopôle de Toulouse, Toulouse, France.